Floatz logo

(8S)-8-ETHYL-2,3-DIHYDRO-8-HYDROXY-15-((4-METHYL-1-PIPERAZINYL)METHYL)-11H-P-DIOXINO(2,3-G)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-9,12(8H,14H)-DIONE

Ovarian Neoplasms

Astellas Pharma IncSmall moleculePhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

79 Active assets in the Ovarian Neoplasms cohort.

Asset / SponsorPhaseRating
Inno-206
GlaxoSmithKline
Phase 4BBB
Carboplatin
Eli Lilly and Company
Phase 3BB
gw786034
The Christie NHS Foundation Trust
Phase 2BB
tlk286
Telik
Phase 3BB
Niraparib
GlaxoSmithKline
Phase 4BB

View all 50 →

Same molecule, other indications

(8S)-8-ETHYL-2,3-DIHYDRO-8-HYDROXY-15-((4-METHYL-1-PIPERAZINYL)METHYL)-11H-P-DIOXINO(2,3-G)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-9,12(8H,14H)-DIONE is also rated in:

Carcinoma, Small CellDormant
B
Indicative ·
57 / 100
View asset →
primary peritoneal carcinomaDormant
B
Indicative ·
57 / 100
View asset →
small cell lung carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →